Investigation reveals 2-ethylhexyl 4-methoxycinnamate and benzophenone-3 affect steroidogenesis, indicating potential estrogenic activity.
We investigated the estrogenic effects of 2-ethylhexyl 4-methoxycinnamate (EHMC) and benzophenone-3 (BP-3) on steroidogenesis in maturing oocytes of the longchin goby. Oocytes with 0.77-, 0.82-, and 0.87-mm diameters were incubated with EHMC (0.5–500 ng/mL) or BP-3 (0.5–500 ng/mL) for 24 h with [³H]17α-hydroxyprogesterone as a precursor. The major steroid metabolites were separated and identified as androstenedione, testosterone (T), estradiol-17β (E 2 ), estrone, and 17,20β-dihydroxy-4-pregnen-3-one (17α20βP). The E 2 metabolite was significantly increased at 5 and 0.5 ng/mL of EHMC in 0.82- and 0.87-mm-diameter oocytes, respectively. Furthermore, it was increased significantly at 5 ng/mL of BP-3 in the oocytes of 0.87 mm. In addition, 5, 50, and 500 ng/mL of EHMC increased the ratio of E 2 /17α20βP in the oocytes of 0.82 mm. 0.5 ng/mL of BP-3 increased the ratio of E 2 /T in the oocytes of 0.87 mm. These results suggest that EHMC and BP-3 have a potential estrogenic activity in the steroidogenic shift process, vitellogenic stage to final maturation stage.
No takes yet. Share an insight, caveat, or question.
Woo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: